Skip to main content
Equibles
INCY logo

INCY · Incyte Corp · Metrics

Track INCY — free

Use INCY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INCY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$116.62 +3.37 (+2.97%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$22.63B
Shares
199.78M
Volume · Oct 20 1.25M Avg daily vol (3M) 1.64M

INCY metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$116.62
Market cap
$22.63B

Price action

20 metrics
Price change (1W)
+1.7%
Price change (30D)
-9.1%
Price change (3M)
-2.1%
Price change (6M)
+16.8%
Price change (YTD)
+14.7%
Price change (1Y)
+29.3%
Trailing year
Price change (5Y)
+73.0%
52-week high
$129.93
52-week low
$86.17
Change from 52-week high
-12.8%
Change from 52-week low
+31.4%
Annualized volatility
33.4%
Annualized volatility (3M)
31.6%
Beta
0.5
RSI (14D)
39.9
Price vs SMA 50
-6.9%
Price vs SMA 200
+5.3%
Avg volume (3M)
1.64M
Relative volume
0.7
Average dollar volume
$198.63M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
199.78M

Valuation

12 metrics
P / E (TTM)
14.4
Trailing earnings · reciprocal yield 6.9%
PEG ratio
0.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.9×
reciprocal yield 25.8%
P / book
3.6
reciprocal yield 28.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
11.4
reciprocal yield 8.8%
Earnings yield
7.1%

Historical valuation

8 metrics
P / E historical average (3Y)
142.6×
reciprocal yield 0.7%
P / E historical average (5Y)
100.2×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
4.0×
reciprocal yield 24.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
40.5×
reciprocal yield 2.5%
EV / EBITDA historical average (3Y)
22.4×
reciprocal yield 4.5%
EV / EBITDA historical average (5Y)
22.4×
reciprocal yield 4.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
92.6%
Operating margin
30.6%
Trailing 12 months
Net margin
27.7%
Gross profit (TTM)
$5.39B
Operating profit (TTM)
$1.78B
Net income (TTM)
$1.61B
Trailing 12 months
Diluted EPS (TTM)
$7.85
FCF margin
—
Effective tax rate
18.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$28.35
Gross profit per diluted share (TTM)
$26.25
Operating profit per diluted share (TTM)
$8.65
EBITDA per diluted share (TTM)
$9.13
Net income per diluted share (TTM)
$7.85
Operating cash flow per diluted share (TTM)
$9.66
Free cash flow per diluted share (TTM)
$3.98
Capital expenditures per diluted share (TTM)
$0.35
R&D per diluted share (TTM)
$10.48
Stock compensation per diluted share (TTM)
$1.24
Book value per share
$31.57

Growth

11 metrics
Revenue growth YoY
+37.7%
Year over year
Net income growth YoY
+44.6%
Revenue (TTM)
$5.82B
Trailing 12 months
EPS growth YoY
+37.7%
Shares change YoY
+4.8%
Year over year · more shares
Revenue CAGR (3Y)
+14.8%
Revenue CAGR (5Y)
+14.0%
EPS CAGR (3Y)
+61.6%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+12.1%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
25.4%
Return on assets
20.5%
Debt / equity
—
Current ratio
4.6
EBITDA (TTM)
$1.88B
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
764.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.98B
Total assets
$7.87B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.98B
Capital expenditures (TTM)
—
R&D (TTM)
$2.15B
SG&A (TTM)
$1.40B
Stock compensation (TTM)
$255.14M
R&D / revenue
37.0%
Stock compensation / revenue
4.4%

Ownership (13F)

9 metrics
13F filers
867
13F filer change QoQ
+47
Institutional ownership
102.0%
Conviction holders (share of 13F filers)
1.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.7%
Holder tenure
19.2
Price vs estimated holder cost
+39.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.7%

Short interest

3 metrics
Short interest
5.0%
Latest settlement · 6.1 days to cover
Days to cover
6.1d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$14.96M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 879169 CUSIP 45337C102 13F (30d) 138 filings 129 filers Visit website Investor relations